{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:15:28Z","timestamp":1791206128320,"version":"4.1.0"},"reference-count":155,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.antiviral.2011.09.002","type":"journal-article","created":{"date-parts":[[2011,9,11]],"date-time":"2011-09-11T09:02:25Z","timestamp":1315731745000},"page":"389-407","source":"Crossref","is-referenced-by-count":141,"title":["Nanobodies\u00ae: New ammunition to battle viruses"],"prefix":"10.1016","volume":"92","author":[{"given":"Peter","family":"Vanlandschoot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catelijne","family":"Stortelers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Beirnaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Itat\u00ed","family":"Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Schepens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Depla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Saelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2011.09.002_b0005","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00018-010-0266-1","article-title":"A llama-derived gelsolin single-domain antibody blocks gelsolin-G-actin interaction","volume":"67","author":"Van den Abbeele","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.antiviral.2011.09.002_b0010","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1073\/pnas.89.19.9339","article-title":"Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro","volume":"89","author":"Barbas","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2011.09.002_b0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10658-007-9265-y","article-title":"Stable recombinant alpaca antibodies for detection of Tulip virus X","volume":"121","author":"Beekwilder","year":"2008","journal-title":"Eur. J. Plant Pathol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0020","doi-asserted-by":"crossref","first-page":"13232","DOI":"10.1128\/JVI.78.23.13232-13252.2004","article-title":"Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies","volume":"78","author":"Binley","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0025","first-page":"1212","article-title":"The development of nanobodies for therapeutic applications","volume":"10","author":"Van Bockstaele","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.antiviral.2011.09.002_b0030","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood-2010-07-296749","article-title":"Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody","volume":"117","author":"Bouchet","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2011.09.002_b0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3748\/wjg.v13.i1.65","article-title":"Hepatitis B virus morphogenesis","volume":"13","author":"Bruss","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/aid.1994.10.359","article-title":"Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization","volume":"10","author":"Buchacher","year":"1994","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2011.09.002_b0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.272.5258.104","article-title":"Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity","volume":"272","author":"Burns","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2011.09.002_b0050","doi-asserted-by":"crossref","first-page":"10134","DOI":"10.1073\/pnas.88.22.10134","article-title":"A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals","volume":"88","author":"Burton","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2011.09.002_b0055","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.7973652","article-title":"Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody","volume":"266","author":"Burton","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2011.09.002_b0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/viro.2000.0279","article-title":"Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies","volume":"271","author":"Calder","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.09.002_b0065","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1128\/AAC.45.10.2807-2812.2001","article-title":"Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae","volume":"45","author":"Conrath","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.09.002_b0070","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1074\/jbc.M007734200","article-title":"Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs","volume":"276","author":"Conrath","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2011.09.002_b0075","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/pro.69","article-title":"Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase","volume":"18","author":"Conrath","year":"2009","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2011.09.002_b0080","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/art.21827","article-title":"Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis","volume":"54","author":"Coppieters","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.antiviral.2011.09.002_b0085","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.1128\/JVI.00927-06","article-title":"Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion","volume":"80","author":"Corth\u00e9sy","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0090","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/JVI.74.9.4028-4038.2000","article-title":"Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells","volume":"74","author":"Czauderna","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0095","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1128\/MCB.25.2.728-739.2005","article-title":"Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo","volume":"25","author":"Daelemans","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nbt0302-251","article-title":"Targeted disruption of the alpha1, 3-galactosyltransferase gene in cloned pigs","volume":"20","author":"Dai","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/CVI.00421-09","article-title":"Effector functions of camelid heavy-chain antibodies in immunity to West Nile virus","volume":"17","author":"Daley","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0110","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1128\/CVI.00287-10","article-title":"Contributions of conventional and heavy-chain IgG to immunity in fetal, neonatal, and adult alpacas","volume":"17","author":"Daley-Bauer","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0115","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/312763a0","article-title":"The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus","volume":"312","author":"Dalgleish","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2011.09.002_b0120","doi-asserted-by":"crossref","first-page":"12132","DOI":"10.1128\/JVI.77.22.12132-12139.2003","article-title":"Intracellularly expressed single-domain antibody against p15 matrix protein prevents the production of porcine retroviruses","volume":"77","author":"Dekker","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0125","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/00007890-200010150-00004","article-title":"Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells","volume":"70","author":"Deng","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2011.09.002_b0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1399-3089.2011.00636.x","article-title":"Infectious risk in xenotransplantation \u2013 what post-transplant screening for the human recipient?","volume":"18","author":"Denner","year":"2011","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.antiviral.2011.09.002_b0135","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.4049\/jimmunol.0903722","article-title":"A novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire","volume":"184","author":"Deschacht","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0140","doi-asserted-by":"crossref","first-page":"26285","DOI":"10.1074\/jbc.M102107200","article-title":"Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody","volume":"276","author":"Desmyter","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2011.09.002_b0145","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsb0996-803","article-title":"Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme","volume":"3","author":"Desmyter","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0150","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1128\/AEM.71.1.442-450.2005","article-title":"Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo","volume":"71","author":"Dolk","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0155","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1110\/ps.34602","article-title":"Single-domain antibody fragments with high conformational stability","volume":"11","author":"Dumoulin","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2011.09.002_b0160","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1021\/bi011239a","article-title":"Biophysical properties of camelid V(HH) domains compared to those of human V(H)3 domains","volume":"41","author":"Ewert","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2011.09.002_b0165","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/infdis\/172.2.389","article-title":"Respiratory syncytial virus and influenza A infections in the hospitalized elderly","volume":"172","author":"Falsey","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.09.002_b0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1053\/jhep.2003.50389","article-title":"New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B","volume":"38","author":"Feld","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2011.09.002_b0175","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0092-8674(95)90436-0","article-title":"The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs","volume":"82","author":"Fischer","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2011.09.002_b0180","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0092-8674(00)80371-2","article-title":"CRM1 is an export receptor for leucine-rich nuclear export signals","volume":"90","author":"Fornerod","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2011.09.002_b0185","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1128\/JVI.01379-08","article-title":"Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120","volume":"82","author":"Forsman","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1742-4690-5-84","article-title":"HIV-1 Nef: at the crossroads","volume":"5","author":"Foster","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.antiviral.2011.09.002_b0195","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/36894","article-title":"CRM1 is responsible for intracellular transport mediated by the nuclear export signal","volume":"390","author":"Fukuda","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2011.09.002_b0200","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.1128\/JVI.00436-08","article-title":"Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice","volume":"82","author":"Garaicoechea","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0205","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.0505379103","article-title":"Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies","volume":"103","author":"De Genst","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2011.09.002_b0210","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1021\/ac0610053","article-title":"Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library","volume":"78","author":"Goldman","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.antiviral.2011.09.002_b0215","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/500470","article-title":"Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin","volume":"193","author":"Goudsmit","year":"2006","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.antiviral.2011.09.002_b0220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/374168a0","article-title":"A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks","volume":"374","author":"Greenberg","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2011.09.002_b0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/labinvest.3700395","article-title":"Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha","volume":"86","author":"Groot","year":"2006","journal-title":"Lab. Invest."},{"key":"10.1016\/j.antiviral.2011.09.002_b0230","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The respiratory syncytial virus immune globulin study group","volume":"329","author":"Groothuis","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2011.09.002_b0235","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00705-007-1055-5","article-title":"Amino acid domains 280\u2013297 of VP6 and 531\u2013554 of VP4 are implicated in heat shock cognate protein hsc70-mediated rotavirus infection","volume":"152","author":"Gualtero","year":"2007","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0240","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1128\/JB.187.13.4531-4541.2005","article-title":"Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection","volume":"187","author":"De Haard","year":"2005","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0245","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus","volume":"344","author":"Hall","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2011.09.002_b0250","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2011.09.002_b0255","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2011.09.002_b0260","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(00)81748-1","article-title":"Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice","volume":"95","author":"Hanna","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2011.09.002_b0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00253-007-1142-2","article-title":"Properties, production, and applications of camelid single-domain antibody fragments","volume":"77","author":"Harmsen","year":"2007","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0270","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0161-5890(00)00081-X","article-title":"Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features","volume":"37","author":"Harmsen","year":"2000","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0275","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1016\/j.vaccine.2005.05.017","article-title":"Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins","volume":"23","author":"Harmsen","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.09.002_b0280","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00253-005-0300-7","article-title":"Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy","volume":"72","author":"Harmsen","year":"2006","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0285","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vetmic.2006.10.029","article-title":"Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease","volume":"120","author":"Harmsen","year":"2007","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0290","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.vetmic.2008.04.030","article-title":"Passive immunization of pigs with bispecific llama single-domain antibody fragments against foot-and-mouth disease and porcine immunoglobulin","volume":"132","author":"Harmsen","year":"2008","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0295","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00253-009-2029-1","article-title":"Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation","volume":"84","author":"Harmsen","year":"2009","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0300","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.vaccine.2009.01.110","article-title":"Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs","volume":"27","author":"Harmsen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.09.002_b0305","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/infdis\/152.5.1083","article-title":"Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model","volume":"152","author":"Hemming","year":"1985","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.09.002_b0310","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJM197903083001004","article-title":"Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children","volume":"300","author":"Henderson","year":"1979","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.antiviral.2011.09.002_b0315","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1016\/S0264-410X(03)00529-2","article-title":"Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus","volume":"21","author":"Hilleman","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.09.002_b0320","doi-asserted-by":"crossref","first-page":"e10482","DOI":"10.1371\/journal.pone.0010482","article-title":"Crystal structure of the neutralizing Llama V(HH) D7 and its mode of HIV-1 gp120 interaction","volume":"5","author":"Hinz","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2011.09.002_b0325","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1096\/fj.09-148213","article-title":"A bispecific Nanobody to provide full protection against lethal scorpion envenoming","volume":"24","author":"Hmila","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.antiviral.2011.09.002_b0330","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0335","doi-asserted-by":"crossref","first-page":"e17665","DOI":"10.1371\/journal.pone.0017665","article-title":"Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules","volume":"6","author":"Hultberg","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2011.09.002_b0340","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1472-6750-7-58","article-title":"Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages","volume":"7","author":"Hultberg","year":"2007","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0345","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/infdis\/jiq168","article-title":"Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection","volume":"203","author":"Iba\u00f1ez","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.09.002_b0350","doi-asserted-by":"crossref","first-page":"20565","DOI":"10.1073\/pnas.1012865107","article-title":"CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells","volume":"107","author":"J\u00e4hnichen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2011.09.002_b0355","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","article-title":"Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus","volume":"176","author":"Johnson","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.09.002_b0360","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3748\/wjg.v13.i1.39","article-title":"Intracellular transport of hepatitis B virus","volume":"13","author":"Kann","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0365","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/312767a0","article-title":"T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV","volume":"312","author":"Klatzmann","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2011.09.002_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2008.10.009","article-title":"Selection and characterization of KDEL-specific VHH antibody fragments and their application in the study of ER resident protein expression","volume":"342","author":"Klooster","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.antiviral.2011.09.002_b0375","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2011.09.002_b0380","doi-asserted-by":"crossref","first-page":"19116","DOI":"10.1074\/jbc.M110.116699","article-title":"Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1","volume":"285","author":"Koh","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2011.09.002_b0385","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.ddtec.2010.03.002","article-title":"Nanobodies-from llamas to therapeutic proteins","volume":"7","author":"Kolkman","year":"2010","journal-title":"Drug Discov. Today: Technol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0390","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/35024089","article-title":"Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice","volume":"407","author":"van der Laan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2011.09.002_b0395","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1068228","article-title":"Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning","volume":"295","author":"Lai","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2011.09.002_b0400","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1093\/emboj\/17.13.3512","article-title":"Potent enzyme inhibitors derived from dromedary heavy-chain antibodies","volume":"17","author":"Lauwereys","year":"1998","journal-title":"EMBO J."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2011.09.002_b0405","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(05)00384-7","article-title":"Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention","volume":"34","author":"Lavanchy","year":"2005","journal-title":"J. Clin. Virol"},{"key":"10.1016\/j.antiviral.2011.09.002_b0410","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bpg.2008.11.002","article-title":"Chronic viral hepatitis as a public health issue in the world","volume":"22","author":"Lavanchy","year":"2008","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0415","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3168\/jds.S0022-0302(02)74204-5","article-title":"Preventing phage lysis of Lactococcus lactis in cheese production using a neutralizing heavy-chain antibody fragment from llama","volume":"85","author":"Ledeboer","year":"2002","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.antiviral.2011.09.002_b0420","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0167-4838(99)00030-8","article-title":"Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies","volume":"1431","author":"van der Linden","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2011.09.002_b0425","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2559.2006.02539.x","article-title":"ES1, a new lung carcinoma antibody \u2013 an immunohistochemical study","volume":"49","author":"Mai","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.antiviral.2011.09.002_b0430","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/338254a0","article-title":"The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA","volume":"338","author":"Malim","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2011.09.002_b0435","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1128\/AEM.02690-10","article-title":"Integrative expression system for delivery of antibody fragments by lactobacilli","volume":"77","author":"Mart\u00edn","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0440","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1023\/A:1002045701064","article-title":"Applications of phage resistance in lactic acid bacteria","volume":"76","author":"Moineau","year":"1999","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.antiviral.2011.09.002_b0445","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0952-7915(97)80110-0","article-title":"Co-receptors for HIV-1 entry","volume":"9","author":"Moore","year":"1997","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0450","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1073\/pnas.102562599","article-title":"Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120\u2013CD4\u2013CCR5 complexes","volume":"99","author":"Moulard","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2011.09.002_b0455","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4161\/hv.3.5.4386","article-title":"Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies","volume":"3","author":"Muhamuda","year":"2007","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.antiviral.2011.09.002_b0460","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","article-title":"Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans","volume":"3","author":"M\u00fcller","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2011.09.002_b0465","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/protein\/7.9.1129","article-title":"Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains","volume":"7","author":"Muyldermans","year":"1994","journal-title":"Protein Eng."},{"key":"10.1016\/j.antiviral.2011.09.002_b0470","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0968-0004(01)01790-X","article-title":"Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains","volume":"26","author":"Muyldermans","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.antiviral.2011.09.002_b0475","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.vetimm.2008.10.299","article-title":"Camelid immunoglobulins and nanobody technology","volume":"128","author":"Muyldermans","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0480","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0960-9822(06)00335-6","article-title":"The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export","volume":"7","author":"Neville","year":"1997","journal-title":"Curr. Biol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0485","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0161-5890(99)00067-X","article-title":"Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies","volume":"36","author":"Nguyen","year":"1999","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0490","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/emboj\/19.5.921","article-title":"Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire","volume":"19","author":"Nguyen","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2011.09.002_b0495","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0161-5890(01)00057-8","article-title":"Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries","volume":"38","author":"Nuttall","year":"2001","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0500","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1086\/508747","article-title":"Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea","volume":"194","author":"Pant","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.09.002_b0505","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.285.5431.1236","article-title":"Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group","volume":"285","author":"Paradis","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2011.09.002_b0510","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3201\/eid1202.050006","article-title":"Rotavirus and severe childhood diarrhea","volume":"12","author":"Parashar","year":"2006","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.09.002_b0515","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm0397-282","article-title":"Infection of human cells by an endogenous retrovirus of pigs","volume":"3","author":"Patience","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2011.09.002_b0520","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1128\/JVI.75.6.2771-2775.2001","article-title":"Multiple groups of novel retroviral genomes in pigs and related species","volume":"75","author":"Patience","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0525","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/bi0009082","article-title":"Thermal unfolding of a llama antibody fragment: a two-state reversible process","volume":"40","author":"P\u00e9rez","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2011.09.002_b0530","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3201\/eid1001.030125","article-title":"Ecologic and geographic distribution of filovirus disease","volume":"10","author":"Peterson","year":"2004","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.09.002_b0535","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1126\/science.1078942","article-title":"Production of alpha 1,3-galactosyltransferase-deficient pigs","volume":"299","author":"Phelps","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2011.09.002_b0540","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nbt0302-231","article-title":"Knocking out xenograft rejection","volume":"20","author":"Platt","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0545","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.micro.52.1.491","article-title":"The HIV-1 Rev protein","volume":"52","author":"Pollard","year":"1998","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0550","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0168-1702(85)90045-0","article-title":"Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat","volume":"3","author":"Prince","year":"1985","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2011.09.002_b0555","doi-asserted-by":"crossref","first-page":"9849","DOI":"10.1073\/pnas.1730940100","article-title":"Nuclear import of hepatitis B virus capsids and release of the viral genome","volume":"100","author":"Rabe","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2011.09.002_b0560","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1128\/JVI.68.8.4821-4828.1994","article-title":"Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1","volume":"68","author":"Roben","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0565","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00262-006-0180-4","article-title":"Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies","volume":"56","author":"Roovers","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.antiviral.2011.09.002_b0570","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1126\/science.1154137","article-title":"The global circulation of seasonal influenza A (H3N2) viruses","volume":"320","author":"Russell","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2011.09.002_b0575","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1128\/JVI.76.14.7293-7305.2002","article-title":"The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120","volume":"76","author":"Sanders","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0580","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00005176-200101000-00009","article-title":"Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea","volume":"32","author":"Sarker","year":"2001","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.antiviral.2011.09.002_b0585","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-3542(00)00111-X","article-title":"Antibodies for the prevention and treatment of viral diseases","volume":"47","author":"Sawyer","year":"2000","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.09.002_b0590","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1099\/vir.0.016063-0","article-title":"Production, characterization and in vitro testing of HBcAg-specific VHH intrabodies","volume":"91","author":"Serruys","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0595","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.22609","article-title":"Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice","volume":"49","author":"Serruys","year":"2009","journal-title":"Hepatology"},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2011.09.002_b0600","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1086\/520586","article-title":"Rapid assembly of sensitive antigen-capture assays for Marburg virus, using in vitro selection of llama single-domain antibodies, at biosafety level 4","volume":"196","author":"Sherwood","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.09.002_b0605","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0022-3476(96)70245-7","article-title":"Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children","volume":"129","author":"Simoes","year":"1996","journal-title":"J. Pediatr."},{"key":"10.1016\/j.antiviral.2011.09.002_b0610","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/viro.2001.0934","article-title":"Productive infection of human primary cells and cell lines with porcine endogenous retroviruses","volume":"285","author":"Specke","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.09.002_b0615","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nsmb1029","article-title":"Lactococcal bacteriophage p2 receptor-binding protein structure suggests a common ancestor gene with bacterial and mammalian viruses","volume":"13","author":"Spinelli","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0620","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.toxicon.2006.11.023","article-title":"Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a na\u00efve phage display library: preliminary findings for antivenom development","volume":"49","author":"Stewart","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.antiviral.2011.09.002_b0625","doi-asserted-by":"crossref","first-page":"e1002072","DOI":"10.1371\/journal.ppat.1002072","article-title":"High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis","volume":"7","author":"Stijlemans","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2011.09.002_b0630","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1074\/jbc.M307341200","article-title":"Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm","volume":"279","author":"Stijlemans","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2011.09.002_b0635","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.molimm.2006.10.020","article-title":"A novel pentamer versus pentamer approach to generating neutralizers of verotoxin 1","volume":"44","author":"Stone","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0640","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jim.2006.10.006","article-title":"The assembly of single domain antibodies into bispecific decavalent molecules","volume":"318","author":"Stone","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.antiviral.2011.09.002_b0645","doi-asserted-by":"crossref","first-page":"9986","DOI":"10.1128\/JVI.72.12.9986-9991.1998","article-title":"Host range and interference studies of three classes of pig endogenous retrovirus","volume":"72","author":"Takeuchi","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0650","first-page":"137","article-title":"Monoclonal antibodies protect against respiratory syncytial virus infection in mice","volume":"52","author":"Taylor","year":"1984","journal-title":"Immunology"},{"key":"10.1016\/j.antiviral.2011.09.002_b0655","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jviromet.2011.02.023","article-title":"A simple quantitative affinity capturing assay of poliovirus antigens and subviral particles by single-domain antibodies using magnetic beads","volume":"173","author":"Thys","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2011.09.002_b0660","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.antiviral.2010.05.012","article-title":"In vitro antiviral activity of single domain antibody fragments against poliovirus","volume":"87","author":"Thys","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.09.002_b0665","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1158\/1535-7163.MCT-07-2384","article-title":"Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology","volume":"7","author":"Tijink","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.antiviral.2011.09.002_b0670","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/39489","article-title":"Two sets of human-tropic pig retrovirus","volume":"389","author":"Le Tissier","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2011.09.002_b0675","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-0134(19980901)32:4<515::AID-PROT9>3.0.CO;2-E","article-title":"Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate","volume":"32","author":"Transue","year":"1998","journal-title":"Proteins"},{"key":"10.1016\/j.antiviral.2011.09.002_b0680","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1128\/JB.188.7.2400-2410.2006","article-title":"Receptor-binding protein of Lactococcus lactis phages: identification and characterization of the saccharide receptor-binding site","volume":"188","author":"Tremblay","year":"2006","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0685","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/JVI.70.2.1100-1108.1996","article-title":"Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1","volume":"70","author":"Trkola","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0690","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2006.02.045","article-title":"Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments","volume":"24","author":"van der Vaart","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.09.002_b0695","doi-asserted-by":"crossref","first-page":"21768","DOI":"10.1074\/jbc.M110.112490","article-title":"An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 rev prevents viral production","volume":"285","author":"Vercruysse","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2011.09.002_b0700","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4161\/rna.8.2.13782","article-title":"Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer","volume":"8","author":"Vercruysse","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0705","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.bbapap.2006.05.011","article-title":"Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation","volume":"1764","author":"Verheesen","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2011.09.002_b0710","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1074\/jbc.M806889200","article-title":"General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold","volume":"284","author":"Vincke","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2011.09.002_b0715","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0161-5890(97)00146-6","article-title":"Comparison of llama VH sequences from conventional and heavy chain antibodies","volume":"34","author":"Vu","year":"1997","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0720","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1128\/IAI.43.2.756-758.1984","article-title":"Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies","volume":"43","author":"Walsh","year":"1984","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2011.09.002_b0725","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/INF.0b013e3181967c16","article-title":"Mechanisms of protection against rotavirus infection and disease","volume":"28","author":"Ward","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2011.09.002_b0730","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/erv.10.45","article-title":"Challenges faced by the global polio eradication initiative","volume":"9","author":"Wassilak","year":"2010","journal-title":"Expert. Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2011.09.002_b0735","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00430-009-0116-7","article-title":"Single domain antibodies: promising experimental and therapeutic tools in infection and immunity","volume":"198","author":"Wesolowski","year":"2009","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0740","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s002510050694","article-title":"The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation","volume":"50","author":"Woolven","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.antiviral.2011.09.002_b0745","first-page":"103","article-title":"Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab","volume":"317","author":"Wu","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0750","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1126\/science.280.5371.1884","article-title":"The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens","volume":"280","author":"Wyatt","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2011.09.002_b0755","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/1566523034578294","article-title":"Molecular therapeutics of HBV","volume":"3","author":"Xu","year":"2003","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.antiviral.2011.09.002_b0760","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1073\/pnas.202398599","article-title":"Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection","volume":"99","author":"Yang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2011.09.002_b0765","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jmb.2003.09.034","article-title":"Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents","volume":"335","author":"Zhang","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2011.09.002_b0770","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature05580","article-title":"Structural definition of a conserved neutralization epitope on HIV-1 gp120","volume":"445","author":"Zhou","year":"2007","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2011.09.002_b0775","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1478-3231.2010.02399.x","article-title":"Hepatitis B virus resistance to antiviral drugs: where are we going?","volume":"31","author":"Zoulim","year":"2011","journal-title":"Liver. Int."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211004402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211004402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T05:04:59Z","timestamp":1712811899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354211004402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":155,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0166354211004402"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2011.09.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}